M2 Pharma - Research and Development

LYNPARZA Approved in the EU for Germline BRCA-mutated Metastatic Pancreatic Cancer

8 July 2020 - - LYNPARZA has been approved in the European Union as a monotherapy for the maintenance treatment of adult patients with germline BRCA1/2 mutations who have metastatic adenocarcinom...

FDA Approves Talaris Therapeutics' IND for Its Allogeneic Cell Therapy FCR001 to Be Evaluated in Patients with a Severe form of Scleroderma

8 July 2020 - - The US Food and Drug Administration has approved US-based biotechnology company Talaris Therapeutics, Inc's Investigational New Drug application for the evaluation of Talaris'...

Ridgeback Biotherapeutics Starts Enrollment for Phase 2 Trial of Potential COVID-19 Treatment

8 July 2020 - - US-based Ridgeback Biotherapeutics has started enrollment in a Phase 2 trial of potential COVID-19 treatment EIDD-2801, the company said.

The new trial will be conducted u...

Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19

8 July 2020 - - US-based biotechnology company Moderna, Inc., (NASDAQ: MRNA), which is developing messenger RNA therapeutics and vaccines, has completed enrollment for both cohorts of the Phase 2 stud...

Soterix Medical receives FDA IDE approval for home-based tDCS-LTE trial for depression; Safe for patients deprived of therapy due to the COVID-19 pandemic

8 July 2020 - Medical company Soterix Medical Inc reported on Tuesday the receipt of the US FDA Investigational Device Exception (IDE) to commence the trial of transcranial Direct Current Stimulation-...

Astex Pharmaceuticals' Inqovi tablets receive US FDA approval

8 July 2020 - Astex Pharmaceuticals Inc, a subsidiary of Otsuka Pharmaceutical Co Ltd, has received approval from the United States Food and Drug Administration (FDA) for its Inqovi (decitabine and ce...